Acasti Pharma Inc. (ACST) Financials

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

ACST Income statement / Annual

Last year (2026), 's total revenue was $0.00, and the percentage change from the previous year is not available. In 2026, 's net income was -$9.49 M. See ,s key income statements, including revenue, expenses, profit, and income.

Period FY-2026 FY-2025 FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 03/31/2026 03/31/2025 03/31/2024 03/31/2023 03/31/2022 03/31/2021 03/31/2020 03/31/2019 03/31/2018 03/31/2017
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $196.00 K $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $11.00 K $124.00 K $15.59 M $76.00 K $2.32 M $3.12 M $2.68 M $1.93 M
Gross Profit $0.00 $0.00 -$11.00 K -$124.00 K -$15.59 M $120.00 K -$2.32 M -$3.12 M -$2.68 M -$1.93 M
Gross Profit Ratio 0 0 0 0 0 0.61 0 0 0 0
Research and Development Expenses $2.41 M $9.51 M $4.63 M $10.12 M $5.56 M $3.38 M $13.97 M $28.73 M $12.13 M $5.38 M
General & Administrative Expenses $8.67 M $7.17 M $6.43 M $7.61 M $9.26 M $5.51 M $5.80 M $4.24 M $3.12 M $2.46 M
Selling & Marketing Expenses $0.00 $0.00 $251.37 K -$661.00 K -$518.00 K $1.14 M -$2.67 M $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $8.67 M $7.17 M $6.67 M $8.15 M $8.75 M $6.66 M $8.46 M $4.24 M $3.12 M $575.92 K
Other Expenses $0.00 $0.00 $5.82 K -$28.84 K $0.00 $0.00 $0.00 $1.00 K $1.00 K $0.00
Operating Expenses $11.08 M $16.68 M $11.30 M $18.25 M $14.30 M $10.04 M $22.43 M $32.97 M $15.25 M $5.96 M
Cost And Expenses $0.00 $0.00 $11.31 M $69.08 M $15.92 M $16.62 M $24.75 M $45.65 M $15.25 M $7.88 M
Interest Income $0.00 $0.00 $908.71 K $246.00 K $77.00 K $107.00 K $336.00 K $355.75 K $55.75 K $87.90 K
Interest Expense $0.00 $0.00 $911.00 K $67.69 M $224.00 K $264.00 K $247.00 K $273.37 K $283.41 K $40.79 K
Depreciation & Amortization $0.00 $7.00 K $11.00 K $124.00 K $924.00 K $924.00 K $2.32 M $3.12 M $2.67 M $1.93 M
EBITDA $0.00 $7.00 K -$14.62 M -$2.42 M -$11.22 M -$9.79 M -$33.33 M -$49.11 M -$17.02 M -$6.03 M
EBITDA Ratio 0 0 0 0 0 -49.96 0 0 0 0
Operating Income Ratio 0 0 0 0 0 -55.32 0 0 0 0
Total Other Income/Expenses Net $0.00 $0.00 $9.03 M $17.11 M $4.87 M -$3.26 M -$1.08 M -$4.91 M -$1.40 M -$114.79 K
Income Before Tax -$9.49 M -$12.77 M -$14.69 M -$51.97 M -$11.04 M -$19.68 M -$25.83 M -$38.62 M -$16.65 M -$7.87 M
Income Before Tax Ratio 0 0 0 0 0 -100.4 0 0 0 0
Income Tax Expense $0.00 $0.00 -$1.78 M -$9.54 M -$1.23 M -$127.00 K -$313.00 K $5.24 M $291.15 K -$90.71 K
Net Income -$9.49 M -$12.77 M -$12.85 M -$42.43 M -$9.82 M -$19.68 M -$25.76 M -$43.86 M -$16.94 M -$7.78 M
Net Income Ratio 0 0 0 0 0 -100.4 0 0 0 0
EPS -0.47 -0.79 -1.35 -5.71 -1.6 -7.96 -8.38 -6.46 -7.75 -34.22
EPS Diluted -0.47 -0.79 -1.35 -5.71 -1.6 -7.96 -8.48 -6.46 -7.75 -34.22
Weighted Average Shares Out $16.51 M $12.09 M $9.53 M $7.44 M $6.14 M $2.47 M $3.07 M $6.79 M $2.19 M $231.00 K
Weighted Average Shares Out Diluted $16.51 M $12.09 M $9.53 M $7.44 M $6.14 M $2.47 M $3.04 M $6.79 M $2.19 M $231.14 K
Link